nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Nephropathy toxic—Cisplatin—esophageal cancer	0.0447	0.0447	CcSEcCtD
Ceftibuten—Aphasia—Capecitabine—esophageal cancer	0.0292	0.0292	CcSEcCtD
Ceftibuten—Body temperature increased—Carboplatin—esophageal cancer	0.0247	0.0247	CcSEcCtD
Ceftibuten—Rigors—Capecitabine—esophageal cancer	0.0232	0.0232	CcSEcCtD
Ceftibuten—Aphasia—Methotrexate—esophageal cancer	0.0217	0.0217	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Cisplatin—esophageal cancer	0.0206	0.0206	CcSEcCtD
Ceftibuten—Nasal congestion—Cisplatin—esophageal cancer	0.0204	0.0204	CcSEcCtD
Ceftibuten—Melaena—Capecitabine—esophageal cancer	0.0185	0.0185	CcSEcCtD
Ceftibuten—Candida infection—Capecitabine—esophageal cancer	0.0181	0.0181	CcSEcCtD
Ceftibuten—Irritability—Cisplatin—esophageal cancer	0.0178	0.0178	CcSEcCtD
Ceftibuten—Dehydration—Cisplatin—esophageal cancer	0.0173	0.0173	CcSEcCtD
Ceftibuten—Pancytopenia—Cisplatin—esophageal cancer	0.0153	0.0153	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0152	0.0152	CcSEcCtD
Ceftibuten—Renal impairment—Capecitabine—esophageal cancer	0.0144	0.0144	CcSEcCtD
Ceftibuten—Renal failure—Cisplatin—esophageal cancer	0.0141	0.0141	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—esophageal cancer	0.0141	0.0141	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—esophageal cancer	0.0138	0.0138	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—esophageal cancer	0.0133	0.0133	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—esophageal cancer	0.0132	0.0132	CcSEcCtD
Ceftibuten—Irritability—Capecitabine—esophageal cancer	0.0131	0.0131	CcSEcCtD
Ceftibuten—Dehydration—Capecitabine—esophageal cancer	0.0128	0.0128	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.0124	0.0124	CcSEcCtD
Ceftibuten—Pancytopenia—Capecitabine—esophageal cancer	0.0113	0.0113	CcSEcCtD
Ceftibuten—Neutropenia—Capecitabine—esophageal cancer	0.0111	0.0111	CcSEcCtD
Ceftibuten—Dysuria—Capecitabine—esophageal cancer	0.0111	0.0111	CcSEcCtD
Ceftibuten—Flatulence—Cisplatin—esophageal cancer	0.0111	0.0111	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0105	0.0105	CcSEcCtD
Ceftibuten—Renal failure—Capecitabine—esophageal cancer	0.0104	0.0104	CcSEcCtD
Ceftibuten—Jaundice—Capecitabine—esophageal cancer	0.0103	0.0103	CcSEcCtD
Ceftibuten—Haematuria—Capecitabine—esophageal cancer	0.0101	0.0101	CcSEcCtD
Ceftibuten—Agranulocytosis—Capecitabine—esophageal cancer	0.00987	0.00987	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—esophageal cancer	0.00976	0.00976	CcSEcCtD
Ceftibuten—Convulsion—Cisplatin—esophageal cancer	0.00972	0.00972	CcSEcCtD
Ceftibuten—Haemoglobin—Capecitabine—esophageal cancer	0.00955	0.00955	CcSEcCtD
Ceftibuten—Haemorrhage—Capecitabine—esophageal cancer	0.0095	0.0095	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.0092	0.0092	CcSEcCtD
Ceftibuten—Anaphylactic shock—Cisplatin—esophageal cancer	0.00915	0.00915	CcSEcCtD
Ceftibuten—Erythema multiforme—Capecitabine—esophageal cancer	0.00898	0.00898	CcSEcCtD
Ceftibuten—Anorexia—Cisplatin—esophageal cancer	0.00873	0.00873	CcSEcCtD
Ceftibuten—Chills—Capecitabine—esophageal cancer	0.00852	0.00852	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—esophageal cancer	0.00839	0.00839	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—esophageal cancer	0.00826	0.00826	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—esophageal cancer	0.00826	0.00826	CcSEcCtD
Ceftibuten—Paraesthesia—Cisplatin—esophageal cancer	0.00822	0.00822	CcSEcCtD
Ceftibuten—Dyspnoea—Cisplatin—esophageal cancer	0.00816	0.00816	CcSEcCtD
Ceftibuten—Flatulence—Capecitabine—esophageal cancer	0.00815	0.00815	CcSEcCtD
Ceftibuten—Dysgeusia—Capecitabine—esophageal cancer	0.0081	0.0081	CcSEcCtD
Ceftibuten—Decreased appetite—Cisplatin—esophageal cancer	0.00796	0.00796	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0079	0.0079	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00781	0.00781	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—esophageal cancer	0.00774	0.00774	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—esophageal cancer	0.00751	0.00751	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—esophageal cancer	0.00735	0.00735	CcSEcCtD
Ceftibuten—Body temperature increased—Cisplatin—esophageal cancer	0.00724	0.00724	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—esophageal cancer	0.00711	0.00711	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—esophageal cancer	0.00707	0.00707	CcSEcCtD
Ceftibuten—Dry mouth—Capecitabine—esophageal cancer	0.00688	0.00688	CcSEcCtD
Ceftibuten—Hypersensitivity—Cisplatin—esophageal cancer	0.00674	0.00674	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—esophageal cancer	0.00669	0.00669	CcSEcCtD
Ceftibuten—Asthenia—Cisplatin—esophageal cancer	0.00657	0.00657	CcSEcCtD
Ceftibuten—Anorexia—Capecitabine—esophageal cancer	0.00643	0.00643	CcSEcCtD
Ceftibuten—Chills—Methotrexate—esophageal cancer	0.00634	0.00634	CcSEcCtD
Ceftibuten—Diarrhoea—Cisplatin—esophageal cancer	0.00626	0.00626	CcSEcCtD
Ceftibuten—Insomnia—Capecitabine—esophageal cancer	0.0061	0.0061	CcSEcCtD
Ceftibuten—Paraesthesia—Capecitabine—esophageal cancer	0.00606	0.00606	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—esophageal cancer	0.00603	0.00603	CcSEcCtD
Ceftibuten—Dyspnoea—Capecitabine—esophageal cancer	0.00602	0.00602	CcSEcCtD
Ceftibuten—Dyspepsia—Capecitabine—esophageal cancer	0.00594	0.00594	CcSEcCtD
Ceftibuten—Decreased appetite—Capecitabine—esophageal cancer	0.00587	0.00587	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00583	0.00583	CcSEcCtD
Ceftibuten—Vomiting—Cisplatin—esophageal cancer	0.00582	0.00582	CcSEcCtD
Ceftibuten—Fatigue—Capecitabine—esophageal cancer	0.00582	0.00582	CcSEcCtD
Ceftibuten—Rash—Cisplatin—esophageal cancer	0.00577	0.00577	CcSEcCtD
Ceftibuten—Constipation—Capecitabine—esophageal cancer	0.00577	0.00577	CcSEcCtD
Ceftibuten—Dermatitis—Cisplatin—esophageal cancer	0.00577	0.00577	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00552	0.00552	CcSEcCtD
Ceftibuten—Nausea—Cisplatin—esophageal cancer	0.00544	0.00544	CcSEcCtD
Ceftibuten—Urticaria—Capecitabine—esophageal cancer	0.00536	0.00536	CcSEcCtD
Ceftibuten—Abdominal pain—Capecitabine—esophageal cancer	0.00533	0.00533	CcSEcCtD
Ceftibuten—Body temperature increased—Capecitabine—esophageal cancer	0.00533	0.00533	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—esophageal cancer	0.00533	0.00533	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—esophageal cancer	0.00502	0.00502	CcSEcCtD
Ceftibuten—Hypersensitivity—Capecitabine—esophageal cancer	0.00497	0.00497	CcSEcCtD
Ceftibuten—Asthenia—Capecitabine—esophageal cancer	0.00484	0.00484	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—esophageal cancer	0.00479	0.00479	CcSEcCtD
Ceftibuten—Pruritus—Capecitabine—esophageal cancer	0.00477	0.00477	CcSEcCtD
Ceftibuten—Diarrhoea—Capecitabine—esophageal cancer	0.00462	0.00462	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—esophageal cancer	0.00454	0.00454	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—esophageal cancer	0.00451	0.00451	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—esophageal cancer	0.00448	0.00448	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—esophageal cancer	0.00447	0.00447	CcSEcCtD
Ceftibuten—Dizziness—Capecitabine—esophageal cancer	0.00446	0.00446	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—esophageal cancer	0.00442	0.00442	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—esophageal cancer	0.00437	0.00437	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00434	0.00434	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—esophageal cancer	0.00433	0.00433	CcSEcCtD
Ceftibuten—Vomiting—Capecitabine—esophageal cancer	0.00429	0.00429	CcSEcCtD
Ceftibuten—Rash—Capecitabine—esophageal cancer	0.00425	0.00425	CcSEcCtD
Ceftibuten—Dermatitis—Capecitabine—esophageal cancer	0.00425	0.00425	CcSEcCtD
Ceftibuten—Headache—Capecitabine—esophageal cancer	0.00423	0.00423	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00411	0.00411	CcSEcCtD
Ceftibuten—Nausea—Capecitabine—esophageal cancer	0.00401	0.00401	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—esophageal cancer	0.00399	0.00399	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—esophageal cancer	0.00397	0.00397	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—esophageal cancer	0.00397	0.00397	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—esophageal cancer	0.0037	0.0037	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—esophageal cancer	0.0036	0.0036	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—esophageal cancer	0.00355	0.00355	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—esophageal cancer	0.00344	0.00344	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—esophageal cancer	0.00332	0.00332	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—esophageal cancer	0.00319	0.00319	CcSEcCtD
Ceftibuten—Rash—Methotrexate—esophageal cancer	0.00317	0.00317	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—esophageal cancer	0.00316	0.00316	CcSEcCtD
Ceftibuten—Headache—Methotrexate—esophageal cancer	0.00315	0.00315	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—esophageal cancer	0.00298	0.00298	CcSEcCtD
